Nasdaqcompany
DevelopingMarket movement

Capricor shares jump pre-market as WMS opens HOPE-3 poster on Deramiocel

Capricor Therapeutics shares rose in pre-market trading as the World Muscle Society's 2026 congress opened and the company's HOPE-3 extension poster went onto its virtual platform.

Why it matters

No digital asset is involved: CAPR is a Nasdaq-listed biotechnology share, and the reported move rests on one outlet describing a conference poster whose data stay under embargo until the congress ends. Without the poster figures or a second source, the pre-market and after-hours prices are uncorroborated and the clinical claims remain those of the company.

Key facts

Capricor Therapeutics shares rose 13.54% to $9.73 in Wednesday pre-market trading.

13.54 %Reported by The Crypto Basic

CAPR closed the Tuesday regular session at $8.57, down 1.61%.

1.61 %Reported by The Crypto Basic

After the Tuesday close, CAPR traded up to $10.28 in after-hours trading.

10.28 USDReported by The Crypto Basic

The World Muscle Society opened its virtual congress platform to registered delegates on Sept. 29, 2026.

Reported by The Crypto Basic

Capricor's late-breaking HOPE-3 open-label-extension poster on Deramiocel was available to registered delegates on the congress virtual platform.

Reported by The Crypto Basic

The poster covers a cross-phase delayed-start analysis and a two-year comparison with natural history, and WMS policy holds late-breaking abstracts under embargo until the congress final day.

Reported by The Crypto Basic

Capricor has said 82 of the 106 patients randomised in HOPE-3 reached the 24-month time point.

82 patientsReported by The Crypto Basic

Of the 82 patients reaching 24 months, 40 were originally assigned to Deramiocel and 42 were initially assigned to placebo.

40 patientsReported by The Crypto Basic

What happened

Capricor Therapeutics shares rose 13.54% to $9.73 in Wednesday pre-market trading while the World Muscle Society's 2026 virtual congress was running, according to The Crypto Basic, which reported that the company's late-breaking HOPE-3 open-label-extension poster on Deramiocel was available to registered delegates on the congress platform. CAPR closed Tuesday at $8.57, down 1.61%, before rising to $10.28 in after-hours trading. The poster covers a cross-phase delayed-start analysis and a two-year comparison with natural history, and the report notes that WMS press policy keeps late-breaking abstracts under embargo until the final day of the congress, so no poster figures were released alongside the announcement. Capricor has previously said 82 of the 106 patients randomised in HOPE-3 reached the 24-month time point, 40 originally assigned to Deramiocel and 42 initially assigned to placebo, and that its WMS presentations would report skeletal-muscle and cardiac outcomes through 24 months. The Crypto Basic also refers to a 12-month HOPE-3 analysis reporting a 54% slowing in upper-limb decline, which it says Capricor and FDA reviewers have evaluated using different statistical approaches. Nothing in the single report shows how the market reacted to the poster contents, which remained under embargo at the time of writing.

How the story developed

  1. Official statement

    World Muscle Society opens virtual congress platform

    WMS opened its virtual congress platform to registered delegates on Sept. 29, with late-breaking poster presentations listed as available online.

    The Crypto Basic

  2. First report

    First report by The Crypto Basic

    Capricor Stock Jumps 14% as WMS Opens HOPE-3 Poster Featuring FDA-Filed Data

    The Crypto Basic

  3. Update

    CAPR closes Tuesday lower then trades sharply higher after hours

    CAPR closed at $8.57, down 1.61%, before rising to $10.28 in after-hours trading, according to The Crypto Basic.

    The Crypto Basic

  4. Update

    HOPE-3 extension poster available to delegates while data stay under embargo

    Capricor's late-breaking poster on Deramiocel was viewable by registered delegates, but WMS policy keeps late-breaking abstracts under embargo until the final day of the congress, so no poster figures were disclosed.

    The Crypto Basic

Affected entities

Original sources

PublisherReportRolePublished
The Crypto Basic
Crypto media
Capricor Stock Jumps 14% as WMS Opens HOPE-3 Poster Featuring FDA-Filed DataOriginal